Alector (ALEC) EBITDA Margin Growth (3y) (2021 - 2026)
Alector (ALEC) EBITDA Margin Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Alector |
193.53 Mn |
-12.98 Mn |
- |
-195,523.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-195,523.00 |
| Dec 31, 2025 |
-24,994.00 |
| Sep 30, 2025 |
-74,610.00 |
| Jun 30, 2025 |
-39,837.00 |
| Mar 31, 2025 |
-90,893.00 |
| Dec 31, 2024 |
39,876.00 |
| Sep 30, 2024 |
-33,435.00 |
| Jun 30, 2024 |
58,492.00 |
| Mar 31, 2024 |
104,363.00 |
| Dec 31, 2023 |
81,827.00 |
| Sep 30, 2023 |
42,447.00 |
| Jun 30, 2023 |
146,326.00 |
| Mar 31, 2023 |
25,851.00 |
| Dec 31, 2022 |
16,203.00 |
| Sep 30, 2022 |
87,099.00 |
| Jun 30, 2022 |
35,976.00 |
| Mar 31, 2022 |
13,393.00 |
| Dec 31, 2021 |
-21,491.00 |
| Sep 30, 2021 |
30,554.00 |
| Jun 30, 2021 |
-68,722.00 |
